Blogs about: Nsclc
Featured Blog
Lung Cancer Study of Novel Oral Drug Sapacitabine at CORT
CORT has opened a phase I-II study of sapacitabine for second-line therapy of unresectable advanced or metastatic non-small cell lung cancer (NSCLC). Sapacitabine is an oral nucleoside analog prodrug … more →
Center for Oncology Research & Treatment--Dallas, TX
Pemetrexed for Non Small Cell Lung Cancer
dundeechest wrote 2 months ago: NICE have released new guidance on the use of Pemetrexed in Non-Small Cell Lung Cancer. Read all abo … more →
The "Now you see it, now you don't" scan
linnea11 wrote 4 months ago: Before I move on, I thought we’d take one last, long view of the before and after CT scans of … more →
Alternative regimens offer easier course for advanced NSCLC
smnewsletters wrote 4 months ago: A new study from Norway suggests a treatment alternative to avoid gemcitabine toxicity in NSCLC. A d … more →
PF-02341066 trial moving to Phase III
— 5 comments
linnea11 wrote 4 months ago: David, Peter and I drove to Boston early this morning for my routine trial appointment. The trial te … more →
Four Weeks
— 6 comments
Sheila wrote 5 months ago: It’s been four weeks since my last chemo. I’ve been working a lot lately and then last w … more →
Gene copy number proving strong indicator of cancer prognosis
smnewsletters wrote 10 months ago: New reports this month highlight the growing importance of gene copy number, as opposed to gene expr … more →
Lung Cancer Study of Novel Oral Drug Sapacitabine at CORT
— 1 comment
bmirtsching wrote 10 months ago: CORT has opened a phase I-II study of sapacitabine for second-line therapy of unresectable advanced … more →
Rare Cancer Presentations: Intraspinal Metastasis of Lung Cancer
— 1 comment
bmirtsching wrote 11 months ago: Author: Barry C. Mirtsching, MD (Center for Oncology Research & Treatment, PA, Dallas, TX) Spin … more →
CORT Study Tests Addition of Avastin (Bevacizumab) in Adjuvant Therapy for Non-Small Cell Lung Cancer
— 1 comment
bmirtsching wrote 1 year ago: Post-operative chemotherapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) has become standard … more →
Tarceva Reaches Phase III Primary Endpoint
lazlo46 wrote 1 year ago: A press release yesterday from Genentech (DNA) reports that its drug Tarceva (erlotinib) reached its … more →
Advances in First-Line Treatment of Unresectable Non-Small Cell Lung Cancer: Pemetrexed Maintenance Therapy
— 1 comment
bmirtsching wrote 1 year ago: Chemotherapy is the initial standard-of-care treatment for unresectable (stage IIIB/IV) non-small ce … more →
Stimuvax Lung Cancer Vaccine Study Continues at CORT
— 1 comment
bmirtsching wrote 1 year ago: CORT opened and enrolled in 2007 the first patient worldwide to the START Study (Stimulating Targete … more →
Myriad Genetics to Refocus on Molecular Diagnostics and Personalized Medicine
danielteper wrote 1 year ago: Myriad Genetics (NASDAQ:MYGN) is ending its venture into drug development. Its Alzheimer’s dru … more →
London Oncology Clinic : Clarity
— 2 comments
abdulazizuk wrote 2 years ago: The consultation at the London Oncology Clinic was very positive. The consultant we met with was ver … more →
The Tarceva Option
abdulazizuk wrote 2 years ago: I was sent a link to a drug called Tarceva. I was supprised to learn that it is being offered in Sco … more →
The 5 Options
— 2 comments
abdulazizuk wrote 2 years ago: On the 21st August my father, myself and brother in law attended an appointment with the Lung Specia … more →
